V S Natarajan

        The Indian Practioner, Vol: XXXIV No.7 July 1981

Fortege** in Common Geriatric
Complaints

V.  S. NATARAJAN,* M.D., M.R.C.P  (UK), F.I.C.A., F.C.C.P.

Consulting  Physician  in  Geriatric  &  General  Medicine, Madras.

Introduction

GERIATRIC  MEDICINE  is  a  new  discipline  in  India.  The problems of old people and their management require special attention and in many ways different from the management of geriatric patients in Western countries.

The common problems of aged persons in our country are mainly nutritional deficiencies irrespective of the person’s socioeconomic status, tuberculosis, diabetes, arthritis,  cancer,  general weakness,  fatigue,  poor sleep,  flatulence,  mild constipation and loss of memory.  This study aims to asses the usefulness of Fortege, an Ayurvedic drug, in the relief of these complaints in geriatric practice.

Fortege

Fortege is described as a tonic for fatigue (nervous, muscular, sexual); keeps one fresh,  alert and energetic;  its ingredients help in toning up neuro-glandular sv, Arms;  is said to help digestion and assimilation, correct flatulence and dyspepsia and to relieve mild constipation; helps in decongesting the congested pro-state and helps to relieve the associated micturition complaints.

Each tablet of Fortege  contains:

Kamboji(Breynia  patens) 56  mg.
Kuncha  beej   (Mucuna  pruriens) 30  mg.
Suddha  Kachura   (Curcuma  zedcaria)  30  mg.
Samudra  sosh  beej  15  mg.
Varadhara beej (Argyria  speciosa) 15  mg.
Varadhara  moo!,   (Argyria  speciosa) 15  mg.
Asan    (Withania somnifera) 7.5  mg.
Vacha     (Acorus calamus) 7.5  mg.
Mari    (Piper  nigrum) 7.5  mg.
Synth    (Zingiber Officinalis) 7.5  mg.
Chini  Kabab   (Cubebs Officinalis’ 7.5 mg.
Kalkara   (Anocyclus pyrethrum) 7.5  mg.
Sukhadver    (Santalum  album) 7.5  mg.
Jaifal,    (Myristica fragrans) 4.5  mg.
Javantri    (Myristica  fragrans  arillus) 3.0  mg.
Laving  (Caryophyllus  aromaticus) 7.5 mg.

Patients and Method

75 patients aged 60 years and more who attended my clinic during 1979-80 ‘A ere taken up for study. The following investigations were made: Urine & Stools examination, Chest X-ray, ECG, Blood Urea, Blood Sugar, routine blood examination.  Patients with ailments like Diabetes, Hypertension, Depression, Cancer, and other diseases were excluded from the study. Fortege was given for 6  weeks to geriatric patients.  Later, the same patient was put on a placebo for another 6 weeks. The results were then analyzed. They were again given a maintenance dose of  Fortege.

Common Geriatric Complaints

Each patient had more than one complaint. Fatigue and lack of energy were present in 57  patients (76%).  General weakness  was  present in 72  patients(9670) prostatic symptoms were present in 24 patients (32%); sexual weakness was present in 6 male patients (8%), failing memory was present in 24 patients(32%); poor sleep was present in 51  patients (68%); flatulence, dyspepsia, mild constipation were present in 24 patients (32%) They were 57 male patients and18 female patients, a total of 75 patients(Table I)

Table   I
Common Geriatric Complaints N=75 (M=57;  F=18)

Complaints Males Females Total %
1. Fatigue & Lack of energy 45 12 57 76
2. General Weakness 54 18 72 96
3. Prostatic Symptoms 24 24 32
4. Sexual Weakness 6 6 8
5. Poor Sleep 39 12 51 68
6. Failing Memory 18 6 24 32
7. Flatulence, Dyspepsia, Mild Constipation 18 6 24 32

Results of Fortege Treatment

The results of 6 weeks of Fortege treatment are as follows:

Fatigue & Lack of Energy: There was a satisfactory improvement in 45 patients (78.9%) and poor improvement in 12 patients (21.1%).

General Weakness: There was a satisfactory improvement in  60 patients (83.3%) and poor improvement in 12 patients (16.7%).

Prostatic Symptoms: There was a satisfactory improvement in 18 patients (75.0%) and the improvement was poor in 6 patients (25.0%).

Sexual Weakness: 6 males had complained of sexual weakness. Three patients showed good improvement and three showed poor improvement.

Failing Memory: 9 patients had satisfactory improvement (37.5%), and improvement was poor in 15 patients (62.5%)

Poor  Sleep: There was a satisfactory improvement in 36  patients (70.6%),  and there was no change in 15 patients (29.4%).

Flatulence, Dyspepsia,  Mild  Constipation: There was a satisfactory  improvement in 15 patients (62.5%) suffering from these complaints,

and there was very little change in 9 patients (37.5%).

The majority of the patients showed satisfactory improvement in common geriatric complaints in response to Fortege treatment.

Table  II

Results of Fortege Treatment (6 weeks)

Complaint Good % Moderate % Total satisfactory improvement % Poor % Total %
Fatigue,

Luck of Energy:

21 36.8 24 42.1 45  78.9 12 26.7 57 100
General Weakness: 27 37.5 33 45.8 60 83.3 12 16.7 72 100
Prostatic Symptoms: 9 37.5 9 37.5 18 75.0 6 25.0 24 100
Sexual Weakness: (Males) 3 50.0 3 50.0 3 50.0 6 100
Failing  Memory : 6 25.0 3 12.5 9  37.5 15  62.5 24 100
Poor Sleep : 15 29.4 21 41.2 36  70.6 15 29.4 51 100
Flatulence, Dyspepsia, Mild constipation: 9 37.5 6 25.0 15   62.5 9 37.5 24 100

Follow Up

After 6 weeks of treatment with Fortege, all the 75 patients were given the only placebo, in the same dosage as Fortege„ for 6 weeks. The symptomatology deteriorated from week to week and by the end of six weeks of placebo treatment, 90%  of the patients complained of symptoms they had before. They were again put on Fortege and they improved. After a further six weeks of Fortege treatment, they were put on a maintenance dose of 2 to 4 Fortege tabs. a day. The patients experienced a sense of well being.

There were  no toxic or untoward effects observed with Fortege treatment

Conclusion

Foirtege,  an  Ayurvedic drug, is found useful in relieving Complaints Cornmcnly saw in geriatric practice.

Acknowledgement

I am thankful to Alarsin  Pharmaceuticals, Bombay, for supplying  Fortege tablets and the placebo required to carry out this clinical study.

References

  1. Bhalerao, M.B., and  Bhalerao, S.M. (1979):  An Ayurvedic Drug  Fortege in

the management of  Oligospermia-19th  Mah. State Med. Conf., Bombay.

  1. Bhaierao, M.N., Bhalerao, S.M., Amarnath, S. and Daithankar, S.G. (1979):

Fortege in  Male  Infertility—A  Controlled  trial-23rd  All  India  Obst.  &

Gynaec.  Congress,  Bangalore, Cur. Med. Pract., XXIV (3): 95-99.

  1. Bhargava, N.C.  and  Singh,  O.P. (1977):  Fortege,  an indigenous drug in

common sexual disorders in males-2nd National Conference of Indian Assn.

for the study of sexually Transmitted Diseases, Madras, Medisccpe, XXI(6):140-44.

  1. Gupta, L.N. and  Saluja,  J.S.(1975):  Role of  Fortege in  Oligospermia Cu.,  Med. Pract. XIX(6): 272-273.
  2. Joshi,  S.K.(1965):  Syndrome of Dhat in the male (use of an Ayurvedic compound): Mah. Med. J., 12:9.

6. Kamlesh Kumar (1979): Management of some male sexual disorders with Fortege-Antiseptic, 76, 3: 145-49.

  1. Shelat, R.K. Majumdar, M., Banderia, B.C. and Basu, K.N. (1977): Useful-ness of Fortege in Oligospermia and low motility of sperms—I Asian
    Congress of Fertility & Sterility, Bombay.
  2. Sukhtankar, V.R. (1960):  A  peculiar anxiety  Syndrome,  Nightmare of millions—Ind. Pract. 13, 12.